Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

June 16, 2016 08:00 ET | Source: Pernix Therapeutics Holdings, Inc.

Pernix Therapeutics Announces Positive Phase IV Results of Silenor® vs. Zolpidem Head-to-Head Arousability Study

Data demonstrated that Pernix Therapeutics’ Silenor® 6 mg was superior to zolpidem 10 mg on all measures evaluated. Study results presented at SLEEP 2016 international meeting MORRISTOWN, N.J.,...
May 05, 2016 08:00 ET | Source: Pernix Therapeutics Holdings, Inc.

Pernix Therapeutics Reports First Quarter 2016 Financial Results and Business Update

Pernix Prescriptions DirectTM Achieves Increased Penetration MORRISTOWN, N.J., May 05, 2016 (GLOBE NEWSWIRE) -- Pernix Therapeutics Holdings, Inc. (NASDAQ:PTX) (“Pernix” or the “Company”), a...
April 28, 2016 08:30 ET | Source: Pernix Therapeutics Holdings, Inc.

Pernix Therapeutics to Report First Quarter 2016 Financial Results on Thursday, May 5, 2016

MORRISTOWN, N.J., April 28, 2016 (GLOBE NEWSWIRE) -- Pernix Therapeutics Holdings, Inc. (NASDAQ:PTX), a specialty pharmaceutical company, announced today that it will release financial results for...
April 05, 2016 16:01 ET | Source: Pernix Therapeutics Holdings, Inc.

Pernix Therapeutics to Present at Needham & Company’s 15th Annual Healthcare Conference

MORRISTOWN, N.J., April 05, 2016 (GLOBE NEWSWIRE) -- Pernix Therapeutics Holdings, Inc. (NASDAQ:PTX), a specialty pharmaceutical company, announced today that Doug Drysdale, Chairman and Chief...
March 02, 2016 08:30 ET | Source: Pernix Therapeutics Holdings, Inc.

Pernix Therapeutics Files Citizen Petition Following Issuance of U.S. Patent Number 9,265,760 (‘760 Patent) Covering Safety Information Related to Dosing Patients with Zohydro ER® with BeadTek™ CII

Morristown, NJ, March 02, 2016 (GLOBE NEWSWIRE) -- Pernix Therapeutics Holdings, Inc. (NASDAQ: PTX), a specialty pharmaceutical company, today announced their submission of a Citizen Petition to...
February 24, 2016 08:43 ET | Source: Pernix Therapeutics Holdings, Inc.

Pernix Therapeutics to Report Fourth Quarter and Full-Year 2015 Financial Results on Thursday, March 10, 2016

MORRISTOWN, N.J., Feb. 24, 2016 (GLOBE NEWSWIRE) -- Pernix Therapeutics Holdings, Inc. (NASDAQ:PTX), a specialty pharmaceutical company, announced today that it will release its fourth quarter and...
November 12, 2015 11:15 ET | Source: Pernix Therapeutics Holdings, Inc.

Pernix Therapeutics Holdings, Inc. Announces Positive Interim Results From a Phase IV Study to Assess and Compare the Effects of Silenor 6 mg and zolpidem 10 mg on Balance, Cognitive Performance, and Arousability

MORRISTOWN, N.J., Nov. 12, 2015 (GLOBE NEWSWIRE) -- Pernix Therapeutics Holdings, Inc. (NASDAQ:PTX), a specialty pharmaceutical company, today announced positive interim results from a Phase IV...
February 27, 2015 14:15 ET | Source: Michael Baker International

USACE, Far East District AP Selects Pernix-Kaseman JV for Construction Project in South Korea

MCLEAN, Va., Feb. 27, 2015 (GLOBE NEWSWIRE) -- Kaseman, a Michael Baker International company, announced that the U.S. Army Corps of Engineers (USACE), Far East District AP has awarded the...
September 12, 2012 11:49 ET | Source: Pamlab LLC

Pamlab LLC and Others Seek U.S. International Trade Commission Action to Block Importation of Certain Medical Food Products and Ingredients

WASHINGTON, Sept. 12, 2012 (GLOBE NEWSWIRE) -- Pamlab LLC, a specialty pharmaceutical company that provides medical foods and foods for special dietary use, has joined Merck & Cie and South...